Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Eckman

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devicesSirtaz Adatya, Roy Sunny, Megan J Fitzpatrick, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 6, 2016
Percutaneous Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Is Associated with Improved Short- and Long-Term SurvivalKatarzyna Hryniewicz, Yader Sandoval, Michael Samara, et al.
Plos One|November 9, 2013
Identification of differentially expressed transcripts and pathways in blood one week and six months following implant of left ventricular assist devicesAdam Mitchell, Weihua Guan, Rodney Staggs, et al.
JACC. Heart Failure|March 16, 2015
Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory supportSirtaz Adatya, Nir Uriel, Hirad Yarmohammadi, et al.
Journal of the American College of Cardiology|February 5, 2011
Clinical, molecular, and genomic changes in response to a left ventricular assist deviceJennifer L Hall, David R Fermin, Emma J Birks, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 22, 2026
Temporary Mechanical Circulatory Support in LVAD Candidates with Right Ventricular Dysfunction: Acuity Without Long-Term FutilityRuben Crespo-Diaz, Katarzyna Hryniewicz, Michael Samara, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human ExperienceTrevor Simard, Marino Labinaz, Firas Zahr, et al.
Plos One|July 18, 2014
Identification of a new target of miR-16, Vacuolar Protein Sorting 4aNeeta Adhikari, Weihua Guan, Brian Capaldo, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2017
Design and Initial Results of the Minneapolis Heart Institute TeleHeart ProgramMarc C Newell, Craig E Strauss, Toby Freier, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 10, 2014
Substance abuse at the time of left ventricular assist device implantation is associated with increased mortalityRebecca Cogswell, Elisa Smith, Aimee Hamel, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devicesSirtaz Adatya, Roy Sunny, Megan J Fitzpatrick, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 6, 2016
Percutaneous Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Is Associated with Improved Short- and Long-Term SurvivalKatarzyna Hryniewicz, Yader Sandoval, Michael Samara, et al.
Plos One|November 9, 2013
Identification of differentially expressed transcripts and pathways in blood one week and six months following implant of left ventricular assist devicesAdam Mitchell, Weihua Guan, Rodney Staggs, et al.
JACC. Heart Failure|March 16, 2015
Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory supportSirtaz Adatya, Nir Uriel, Hirad Yarmohammadi, et al.
Journal of the American College of Cardiology|February 5, 2011
Clinical, molecular, and genomic changes in response to a left ventricular assist deviceJennifer L Hall, David R Fermin, Emma J Birks, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 22, 2026
Temporary Mechanical Circulatory Support in LVAD Candidates with Right Ventricular Dysfunction: Acuity Without Long-Term FutilityRuben Crespo-Diaz, Katarzyna Hryniewicz, Michael Samara, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human ExperienceTrevor Simard, Marino Labinaz, Firas Zahr, et al.
Plos One|July 18, 2014
Identification of a new target of miR-16, Vacuolar Protein Sorting 4aNeeta Adhikari, Weihua Guan, Brian Capaldo, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2017
Design and Initial Results of the Minneapolis Heart Institute TeleHeart ProgramMarc C Newell, Craig E Strauss, Toby Freier, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 10, 2014
Substance abuse at the time of left ventricular assist device implantation is associated with increased mortalityRebecca Cogswell, Elisa Smith, Aimee Hamel, et al.
Pageof 5